RU2011106036A - WAYS TO IMPROVE THE QUALITY OF LIFE OF THE MATURE ANIMAL ANIMAL - Google Patents

WAYS TO IMPROVE THE QUALITY OF LIFE OF THE MATURE ANIMAL ANIMAL Download PDF

Info

Publication number
RU2011106036A
RU2011106036A RU2011106036/10A RU2011106036A RU2011106036A RU 2011106036 A RU2011106036 A RU 2011106036A RU 2011106036/10 A RU2011106036/10 A RU 2011106036/10A RU 2011106036 A RU2011106036 A RU 2011106036A RU 2011106036 A RU2011106036 A RU 2011106036A
Authority
RU
Russia
Prior art keywords
animal
composition
geriatric
group
quality
Prior art date
Application number
RU2011106036/10A
Other languages
Russian (ru)
Other versions
RU2513698C2 (en
Inventor
Райан Майкл ЯМКА (US)
Райан Майкл ЯМКА
Ким Джин ФРИЗЕН (US)
Ким Джин ФРИЗЕН
Original Assignee
Хилл'С Пет Ньютришн, Инк. (Us)
Хилл'С Пет Ньютришн, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Хилл'С Пет Ньютришн, Инк. (Us), Хилл'С Пет Ньютришн, Инк. filed Critical Хилл'С Пет Ньютришн, Инк. (Us)
Publication of RU2011106036A publication Critical patent/RU2011106036A/en
Application granted granted Critical
Publication of RU2513698C2 publication Critical patent/RU2513698C2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/20—Feeding-stuffs specially adapted for particular animals for horses
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Abstract

1. Способ улучшения качества жизни половозрелого и гериатрического животного, включающий кормление животного композицией, содержащей питательные элементы в основном в соответствии с композицией, выбираемой из следующих композиций А, В и С, определенных из расчета на сухую массу: !   А В С Питательный компонент       Сырой белок, % 20,1 19,3 35,7 Жир, % 16,5 16,9 22,5 Кальций, % 0,7 0,7 0,9 Фосфор, % 0,6 0,7 0,8 ЕРА, % 0,3 0,3 0,2 DHA, % 0,2 0,2 0,3 Линолевая кислота, % 4 4 5,1 Все N-3 жирные кислоты, % 1,3 2,2 1,1 Все N-6 жирные кислоты, % 4 4 5,1 Таурин, млн-1 1400 1525 2100 Карнитин, млн-1 314 337 367 Метионин, % 1 1,2 1,3 Цистин, % 0,3 0,2 0,5 Марганец, % 87 100 104 Витамин Е, МЕ/кг 1492 1525 1292 Витамин С, млн-1 127 261 141 Липоевая кислота, млн-1 101 135   ! 2. Способ по п.1, где способ включает кормление животного композицией в количестве, эффективном для повышения качества жизни животного, где повышенное качество жизни подтверждено улучшением одной или нескольких характеристик, выбираемых из группы, состоящей из настороженности, жизнеспособности, защиты хряща, поддержания мышечной массы и качества кожи и шерсти. ! 3. Способ по п.1, где способ включает кормление животного композицией в количестве, эффективном для повышения настороженности. ! 4. Способ по п.1, где способ включает кормление животного композицией в количестве, эффективном для повышения жизнеспособности. ! 5. Способ по п.1, где способ включает кормление животного композицией в количестве, эффективном для защиты хряща. ! 6. Способ по п.1, где способ включает кормление животного композицией в количестве, эффективном для поддержания мышечной массы. ! 7. Способ по п.1, где способ включает кормление животного композицией в количестве, эф 1. A method of improving the quality of life of a sexually mature and geriatric animal, comprising feeding the animal a composition containing nutrients, mainly in accordance with a composition selected from the following compositions A, B and C, calculated on the basis of dry weight:! A B C Nutrient component Crude protein,% 20.1 19.3 35.7 Fat,% 16.5 16.9 22.5 Calcium,% 0.7 0.7 0.9 Phosphorus,% 0.6 0, 7 0.8 EPA,% 0.3 0.3 0.2 DHA,% 0.2 0.2 0.3 Linoleic acid,% 4 4 5.1 All N-3 fatty acids,% 1.3 2, 2 1.1 All N-6 fatty acids,% 4 4 5.1 Taurine, ppm 1400 1525 2100 Carnitine, ppm 314 337 367 Methionine,% 1 1.2 1.3 Cystine,% 0.3 0 , 2 0.5 Manganese,% 87 100 104 Vitamin E, IU / kg 1492 1525 1292 Vitamin C, ppm 127 261 141 Lipoic acid, ppm 101 135! 2. The method according to claim 1, where the method includes feeding the animal a composition in an amount effective to improve the quality of life of the animal, where the increased quality of life is confirmed by improving one or more characteristics selected from the group consisting of alertness, vitality, cartilage protection, muscle maintenance mass and quality of skin and coat. ! 3. The method according to claim 1, where the method includes feeding the animal a composition in an amount effective to increase alertness. ! 4. The method according to claim 1, where the method includes feeding the animal the composition in an amount effective to increase viability. ! 5. The method according to claim 1, where the method comprises feeding the animal a composition in an amount effective to protect cartilage. ! 6. The method according to claim 1, where the method includes feeding the animal the composition in an amount effective to maintain muscle mass. ! 7. The method according to claim 1, where the method includes feeding the animal the composition in an amount, eff

Claims (39)

1. Способ улучшения качества жизни половозрелого и гериатрического животного, включающий кормление животного композицией, содержащей питательные элементы в основном в соответствии с композицией, выбираемой из следующих композиций А, В и С, определенных из расчета на сухую массу:1. A method of improving the quality of life of a sexually mature and geriatric animal, comprising feeding the animal a composition containing nutrients mainly in accordance with a composition selected from the following compositions A, B and C, based on dry weight:   АBUT ВAT СFROM Питательный компонентNutritional component       Сырой белок, %Crude protein,% 20,120.1 19,319.3 35,735.7 Жир, %Fat% 16,516.5 16,916.9 22,522.5 Кальций, %Calcium% 0,70.7 0,70.7 0,90.9 Фосфор, %Phosphorus,% 0,60.6 0,70.7 0,80.8 ЕРА, %EPA,% 0,30.3 0,30.3 0,20.2 DHA, %DHA% 0,20.2 0,20.2 0,30.3 Линолевая кислота, %Linoleic acid,% 4four 4four 5,15.1 Все N-3 жирные кислоты, %All N-3 fatty acids,% 1,31.3 2,22.2 1,11,1 Все N-6 жирные кислоты, %All N-6 fatty acids,% 4four 4four 5,15.1 Таурин, млн-1 Taurine, mn -1 14001400 15251525 21002100 Карнитин, млн-1 Carnitine, mn -1 314314 337337 367367 Метионин, %Methionine,% 1one 1,21,2 1,31.3 Цистин, %Cystine,% 0,30.3 0,20.2 0,50.5 Марганец, %Manganese,% 8787 100one hundred 104104 Витамин Е, МЕ/кгVitamin E, IU / kg 14921492 15251525 12921292 Витамин С, млн-1 Vitamin C mn -1 127127 261261 141141 Липоевая кислота, млн-1 Lipoic acid, mn -1 101101 135135  
2. Способ по п.1, где способ включает кормление животного композицией в количестве, эффективном для повышения качества жизни животного, где повышенное качество жизни подтверждено улучшением одной или нескольких характеристик, выбираемых из группы, состоящей из настороженности, жизнеспособности, защиты хряща, поддержания мышечной массы и качества кожи и шерсти.2. The method according to claim 1, where the method includes feeding the animal a composition in an amount effective to improve the quality of life of the animal, where the increased quality of life is confirmed by improving one or more characteristics selected from the group consisting of alertness, vitality, cartilage protection, muscle maintenance mass and quality of skin and coat. 3. Способ по п.1, где способ включает кормление животного композицией в количестве, эффективном для повышения настороженности.3. The method according to claim 1, where the method includes feeding the animal the composition in an amount effective to increase alertness. 4. Способ по п.1, где способ включает кормление животного композицией в количестве, эффективном для повышения жизнеспособности.4. The method according to claim 1, where the method includes feeding the animal the composition in an amount effective to increase viability. 5. Способ по п.1, где способ включает кормление животного композицией в количестве, эффективном для защиты хряща.5. The method according to claim 1, where the method includes feeding the animal the composition in an amount effective to protect cartilage. 6. Способ по п.1, где способ включает кормление животного композицией в количестве, эффективном для поддержания мышечной массы.6. The method according to claim 1, where the method includes feeding the animal the composition in an amount effective to maintain muscle mass. 7. Способ по п.1, где способ включает кормление животного композицией в количестве, эффективном для улучшения качества кожи и шерсти.7. The method according to claim 1, where the method includes feeding the animal a composition in an amount effective to improve the quality of the skin and coat. 8. Способ по п.1, в котором животное представляет собой кошку или собаку.8. The method according to claim 1, in which the animal is a cat or dog. 9. Способ по п.1, в котором композиция содержит:9. The method according to claim 1, in which the composition contains: по меньшей мере, одну омега-3 полиненасыщенную жирную кислоту, выбираемую из группы, состоящей из докозагексаеновой кислоты и эйкозапентаеновой кислоты;at least one omega-3 polyunsaturated fatty acid selected from the group consisting of docosahexaenoic acid and eicosapentaenoic acid; по меньшей мере, один антиоксидант; и,at least one antioxidant; and, по меньшей мере, одно питательное вещество, выбираемое из группы, состоящей из холина, марганца, метионина, цистеина, L-карнитина, лизина и их смесей.at least one nutrient selected from the group consisting of choline, manganese, methionine, cysteine, L-carnitine, lysine, and mixtures thereof. 10. Способ по п.9, в котором омега-3 полиненасыщенная жирная кислота в композиции представляет собой DHA и в котором композиция содержит, по меньшей мере, примерно 0,02 мас.% DHA, как определено в расчете на сухое вещество.10. The method according to claim 9, in which the omega-3 polyunsaturated fatty acid in the composition is DHA and in which the composition contains at least about 0.02 wt.% DHA, as determined on a dry matter basis. 11. Способ по п.9, в котором омега-3 полиненасыщенная жирная кислота в композиции представляет собой DHA и в котором композиция содержит от примерно 0,02 мас.% до примерно 0,40 мас.% DHA, как определено в расчете на сухое вещество.11. The method according to claim 9, in which the omega-3 polyunsaturated fatty acid in the composition is DHA and in which the composition contains from about 0.02 wt.% To about 0.40 wt.% DHA, as determined on a dry basis substance. 12. Способ по п.9, в котором омега-3 полиненасыщенная жирная кислота в композиции представляет собой ЕРА и в котором композиция содержит, по меньшей мере, примерно 0,1 мас.% EPA, как определено в расчете на сухое вещество.12. The method according to claim 9, in which the omega-3 polyunsaturated fatty acid in the composition is EPA and in which the composition contains at least about 0.1 wt.% EPA, as determined on a dry matter basis. 13. Способ по п.9, в котором омега-3 полиненасыщенная жирная кислота в композиции представляет собой ЕРА и в котором композиция содержит от примерно 0,1 мас.% до примерно 1 мас.% EPA, как определено в расчете на сухое вещество.13. The method according to claim 9, in which the omega-3 polyunsaturated fatty acid in the composition is EPA and in which the composition contains from about 0.1 wt.% To about 1 wt.% EPA, as determined on a dry matter basis. 14. Способ по п.9, в котором омега-3 полиненасыщенная жирная кислота в композиции представляет собой смесь DHA и ЕРА и в котором композиция содержит, по меньшей мере, примерно 0,02 мас.% DHA и, по меньшей мере, примерно 0,1 мас.% EPA в расчете насухое вещество.14. The method according to claim 9, in which the omega-3 polyunsaturated fatty acid in the composition is a mixture of DHA and EPA and in which the composition contains at least about 0.02 wt.% DHA and at least about 0 , 1 wt.% EPA calculated as dry matter. 15. Способ по п.9, в котором композиция содержит один или несколько антиоксидантов, выбираемых из группы, состоящей из витамина Е, витамина С, таурина, бета-каротина, карнитина, липоевой кислоты и цистина.15. The method according to claim 9, in which the composition contains one or more antioxidants selected from the group consisting of vitamin E, vitamin C, taurine, beta-carotene, carnitine, lipoic acid and cystine. 16. Способ по п.9, в котором композиция содержит, по меньшей мере, примерно 500 МЕ/кг витамина Е, по меньшей мере, примерно 50 млн-1 витамина С и, по меньшей мере, примерно 600 млн-1 таурина.16. The method of claim 9, wherein the composition comprises at least about 500 IU / kg vitamin E, at least about 50 million -1 vitamin C and at least about 600 million -1 taurine. 17. Способ по п.9, в котором композиция еще содержит, по меньшей мере, примерно 1000 млн-1 холина.17. The method of claim 9, wherein the composition further comprises at least about 1000 million -1 choline. 18. Способ по п.9, в котором композиция, скармливаемая животному, представляет собой лакомство для животного или игрушку для животного.18. The method according to claim 9, in which the composition fed to the animal is a treat for the animal or a toy for the animal. 19. Способ по п.9, в котором композиция, скармливаемая животному, представляет собой питательную добавку.19. The method according to claim 9, in which the composition fed to the animal is a nutritional supplement. 20. Способ по п.1, в котором животное представляет собой собаку мелкой или стандартной породы, и композиция содержит:20. The method according to claim 1, wherein the animal is a small or standard breed dog, and the composition comprises: от примерно 60 мас.% до примерно 70 мас.% углевода;from about 60 wt.% to about 70 wt.% carbohydrate; от примерно 15 мас.% до примерно 25 мас.% белка, выбираемого из группы, состоящей из животного белка и растительного белка;from about 15 wt.% to about 25 wt.% of a protein selected from the group consisting of animal protein and vegetable protein; от примерно 5 мас.% до примерно 7 мас.% жира, выбираемого из группы, состоящей из животного жира и растительного жира;from about 5 wt.% to about 7 wt.% fat selected from the group consisting of animal fat and vegetable fat; от примерно 2,5 мас.% до примерно 4 мас.%, по меньшей мере, одной из омега-3 полиненасыщенных жирных кислот;from about 2.5 wt.% to about 4 wt.%, at least one of the omega-3 polyunsaturated fatty acids; от примерно 1 мас.% до примерно 2 мас.% волокнистой массы;from about 1 wt.% to about 2 wt.% fibrous mass; от примерно 1 мас.% до примерно 2 мас.% минералов; иfrom about 1 wt.% to about 2 wt.% minerals; and от примерно 0,5 мас.% до примерно 1,5 мас.% витаминов.from about 0.5 wt.% to about 1.5 wt.% vitamins. 21. Способ по п.1, в котором животное представляет собой собаку крупной породы, и композиция содержит:21. The method according to claim 1, in which the animal is a large breed dog, and the composition comprises: от примерно 60 мас.% до примерно 70 мас.% углевода;from about 60 wt.% to about 70 wt.% carbohydrate; от примерно 15 мас.% до примерно 25 мас.% белка, выбираемого из группы, состоящей из животного белка и растительного белка;from about 15 wt.% to about 25 wt.% of a protein selected from the group consisting of animal protein and vegetable protein; от примерно 5 мас.% до примерно 7 мас.% жира, выбираемого из группы, состоящей из животного жира и растительного жира;from about 5 wt.% to about 7 wt.% fat selected from the group consisting of animal fat and vegetable fat; от примерно 3 мас.% до примерно 5 мас.%, по меньшей мере, одной из омега-3 полиненасыщенных жирных кислот;from about 3 wt.% to about 5 wt.%, at least one of the omega-3 polyunsaturated fatty acids; от примерно 1 мас.% до примерно 1,5 мас.% волокнистой массы;from about 1 wt.% to about 1.5 wt.% fibrous mass; от примерно 0,5 мас.% до примерно 1 мас.% минералов; иfrom about 0.5 wt.% to about 1 wt.% minerals; and от примерно 0,75 мас.% до примерно 1,25 мас.% витаминов.from about 0.75 wt.% to about 1.25 wt.% vitamins. 22. Способ по п.1, в котором животное представляет собой кошку, и композиция содержит:22. The method according to claim 1, in which the animal is a cat, and the composition comprises: от примерно 30 мас.% до примерно 35 мас.% углевода;from about 30 wt.% to about 35 wt.% carbohydrate; от примерно 40 мас.% до примерно 50 мас.% белка, выбираемого из группы, состоящей из животного белка и растительного белка;from about 40 wt.% to about 50 wt.% a protein selected from the group consisting of animal protein and vegetable protein; от примерно 12 мас.% до примерно 15 мас.% жира, выбираемого из группы, состоящей из животного жира и растительного жира;from about 12 wt.% to about 15 wt.% fat selected from the group consisting of animal fat and vegetable fat; от примерно 1 мас.% до примерно 2 мас.%, по меньшей мере, одной из омега-3 полиненасыщенных жирных кислот;from about 1 wt.% to about 2 wt.%, at least one of the omega-3 polyunsaturated fatty acids; от примерно 3 мас.% до примерно 5 мас.% волокнистой массы;from about 3 wt.% to about 5 wt.% fibrous mass; от примерно 1 мас.% до примерно 2 мас.% минералов; иfrom about 1 wt.% to about 2 wt.% minerals; and от примерно 1 мас.% до примерно 2 мас.% витаминов.from about 1 wt.% to about 2 wt.% vitamins. 23. Способ по п.1, где способ включает кормление животного композицией в количестве, эффективном для повышения качества жизни животного, в котором повышенное качество жизни подтверждено улучшением в одном или нескольких биологических путях обмена, выбираемых из группы, состоящей из свертывания крови, активации и агрегации тромбоцитов, целостности костей и мышц, воспалительных реакций, разрушения хряща и болевого ответа, повреждения и путей репарации ДНК, нейральной функции, синтеза и деградации гликогена, гликолиза, глюконеогенеза, пентозного фосфатного пути и электронного транспорта.23. The method according to claim 1, where the method includes feeding the animal a composition in an amount effective to improve the quality of life of the animal, in which the improved quality of life is confirmed by an improvement in one or more biological metabolic pathways selected from the group consisting of blood coagulation, activation, and platelet aggregation, bone and muscle integrity, inflammatory reactions, destruction of cartilage and pain response, damage and DNA repair pathways, neural function, glycogen synthesis and degradation, glycolysis, gluconeogenesis, pento Foot phosphate pathway and electron transport. 24. Способ по п.1, где способ включает кормление животного композицией в количестве, эффективном для повышения качества жизни животного, в котором повышенное качество жизни подтверждено изменением в экспрессии одного или нескольких генов, которые кодируют белки, связанные с или относящиеся к биологическим путям обмена, выбираемым из группы, состоящей из свертывания крови и активации и агрегации тромбоцитов, целостности костей и мышц, воспалительных реакций, разрушения хряща и болевого ответа, повреждения и путей репарации ДНК, нейральной функции, синтеза и деградации гликогена, гликолиза, глюконеогенеза, пентозного фосфатного пути и электронного транспорта.24. The method according to claim 1, where the method includes feeding the animal the composition in an amount effective to improve the quality of life of the animal, in which the increased quality of life is confirmed by a change in the expression of one or more genes that encode proteins associated with or related to biological metabolic pathways selected from the group consisting of blood coagulation and platelet activation and aggregation, bone and muscle integrity, inflammatory reactions, destruction of cartilage and pain response, damage and DNA repair pathways, neural functions, synthesis and degradation of glycogen, glycolysis, gluconeogenesis, pentose phosphate pathway and electron transport. 25. Способ по п.1, в котором животное страдает от расстройства или заболевания, связанного с или относящегося к биологическому пути обмена, выбираемому из группы, состоящей из свертывания крови и активации и агрегации тромбоцитов, целостности костей и мышц, воспалительных реакций, разрушения хряща и болевого ответа, повреждения и путей репарации ДНК, нейральной функции, синтеза и деградации гликогена, гликолиза, глюконеогенеза, пентозного фосфатного пути и электронного транспорта, включающий введение упомянутому животному композиции корма для гериатрического домашнего животного.25. The method according to claim 1, in which the animal suffers from a disorder or disease associated with or related to a biological pathway of exchange selected from the group consisting of blood coagulation and activation and aggregation of platelets, integrity of bones and muscles, inflammatory reactions, destruction of cartilage and pain response, damage and DNA repair pathways, neural function, synthesis and degradation of glycogen, glycolysis, gluconeogenesis, pentose phosphate pathway and electron transport, including the introduction of a feed composition to said animal but for a geriatric pet. 26. Способ по п.25, в котором упомянутая композиция корма для гериатрического домашнего животного содержит, по меньшей мере, примерно 9 мас.% белка, по меньшей мере, примерно 5 мас.% жира и, по меньшей мере, примерно 0,05 мас.%, по меньшей мере, одной омега-3 полиненасыщенной жирной кислоты.26. The method according A.25, in which the aforementioned feed composition for a geriatric pet contains at least about 9 wt.% Protein, at least about 5 wt.% Fat and at least about 0.05 wt.%, at least one omega-3 polyunsaturated fatty acid. 27. Способ по п.25, в котором упомянутая композиция корма для гериатрического домашнего животного содержит, по меньшей мере, одну омега-3 полиненасыщенную жирную кислоту, выбираемую из группы, состоящей из докозагексаеновой кислоты (“DHA”) и эйкозапентаеновой кислоты (“ЕРА”).27. The method of claim 25, wherein said geriatric pet food composition comprises at least one omega-3 polyunsaturated fatty acid selected from the group consisting of docosahexaenoic acid (“DHA”) and eicosapentaenoic acid (“EPA” ”). 28. Способ по п.25, в котором упомянутая композиция корма для гериатрического домашнего животного дополнительно содержит, по меньшей мере, один антиоксидант и, по меньшей мере, одно питательное вещество, выбираемое из группы, состоящей из холина, марганца, метионина, цистеина, L-карнитина, лизина и их смесей.28. The method of claim 25, wherein said geriatric pet food composition further comprises at least one antioxidant and at least one nutrient selected from the group consisting of choline, manganese, methionine, cysteine, L-carnitine, lysine and mixtures thereof. 29. Способ по п.25, в котором упомянутая композиция корма для гериатрического домашнего животного содержит компоненты, раскрытые в таблице 1 или таблице 1А.29. The method of claim 25, wherein said geriatric pet food composition comprises the components disclosed in Table 1 or Table 1A. 30. Способ по п.1, в котором животное страдает от расстройства или заболевания, связанного с или относящегося к биологическому пути обмена, выбираемому из группы, состоящей из свертывания крови и активации и агрегации тромбоцитов, целостности костей и мышц, воспалительных реакций, разрушения хряща и болевого ответа, повреждения и путей репарации ДНК, нейральной функции, синтеза и деградации гликогена, гликолиза, глюконеогенеза, пентозного фосфатного пути и электронного транспорта, включающий модулирование уровня экспрессии одного или нескольких генов, перечисленных в таблицах 5-14, в упомянутом животном, чтобы имитировать образец экспрессии, наблюдаемой in vivo после введения композиции корма для гериатрического домашнего животного.30. The method according to claim 1, in which the animal suffers from a disorder or disease associated with or related to a biological metabolic pathway selected from the group consisting of blood coagulation and platelet activation and aggregation, bone and muscle integrity, inflammatory reactions, cartilage destruction and pain response, damage and DNA repair pathways, neural function, synthesis and degradation of glycogen, glycolysis, gluconeogenesis, pentose phosphate pathway and electron transport, including modulating the expression level of one or not nly genes listed in Tables 5-14 in said animal in order to mimic the pattern of expression observed in vivo after administration of the feed composition for geriatric pet. 31. Способ по п.30, в котором упомянутая композиция корма для гериатрического домашнего животного содержит компоненты, раскрытые в таблице 1 или таблице 1А.31. The method of claim 30, wherein said geriatric pet food composition comprises the components disclosed in table 1 or table 1A. 32. Способ для измерения повышения в качестве жизни животного, питавшегося композицией корма для гериатрического домашнего животного, причем включающий количественное определение уровней экспрессии генов для одного или нескольких генов, выбираемых из группы, состоящей из таковых, раскрытых в таблицах 5-14, в упомянутом животном, и сравнение упомянутых уровней в животном с уровнями в животном перед введением упомянутой композиции корма для гериатрического домашнего животного.32. A method for measuring an increase in the quality of life of an animal fed a food composition for a geriatric domestic animal, the method comprising quantifying the expression levels of genes for one or more genes selected from the group consisting of those disclosed in Tables 5-14 in said animal , and comparing said levels in an animal with levels in an animal before administering said geriatric pet food composition. 33. Способ по п.32, в котором упомянутая композиция корма для гериатрического домашнего животного содержит компоненты, раскрытые в таблице 1 или таблице 1А.33. The method according to p, in which the said pet food composition for a geriatric pet contains the components disclosed in table 1 or table 1A. 34. Способ повышения качества жизни животного модулированием уровня экспрессии одного или нескольких генов, перечисленных в таблицах 5-14, в упомянутом животном, чтобы имитировать образец экспрессии, наблюдаемой in vivo после введения композиции корма для гериатрического домашнего животного.34. A method of improving an animal’s quality of life by modulating the expression level of one or more genes listed in Tables 5-14 in said animal to mimic an expression pattern observed in vivo after administration of a geriatric pet food composition. 35. Способ по п.34, в котором упомянутая композиция корма для гериатрического домашнего животного содержит компоненты, раскрытые в таблице 1 или таблице 1А.35. The method according to clause 34, in which said feed composition for a geriatric pet contains the components disclosed in table 1 or table 1A. 36. Способ идентификации животного, которое могло бы получать пользу от съедания композиции корма для гериатрического домашнего животного, включающий измерение уровней экспрессии генов для любого одного или нескольких генов, перечисленных в таблицах 5-14, в упомянутом животном и сравнение упомянутых уровней с уровнями экспрессии генов, представленными в таблицах 5-14, где животное с уровнями, отличающимися от уровней, представленных в таблицах 5-14, было бы идентифицировано как потенциально получившее пользу от съедания композиции по данному изобретению.36. A method of identifying an animal that could benefit from eating a food composition for a geriatric pet, comprising measuring the levels of gene expression for any one or more genes listed in Tables 5-14 in said animal and comparing said levels with gene expression levels presented in tables 5-14, where an animal with levels different from the levels presented in tables 5-14 would be identified as potentially benefiting from eating the composition of this invention. 37. Способ по п.36, в котором упомянутая композиция корма для гериатрического домашнего животного содержит компоненты, раскрытые в таблице 1 или таблице 1А.37. The method according to clause 36, in which said feed composition for a geriatric pet contains the components disclosed in table 1 or table 1A. 38. Способ по п.23, в котором упомянутое животное выбрано из группы, состоящей из половозрелых и гериатрических псовых крупной породы, псовых стандартной породы, псовых мелкой породы или кошачьих.38. The method according to item 23, in which the said animal is selected from the group consisting of sexually mature and geriatric dogs of large breed, canine standard breed, canine small breed or feline. 39. Набор для определения уровней мРНК и/или уровней белка в любом одном или нескольких генах, раскрытых в таблицах 5-14 настоящего описания, в биологическом образце, причем упомянутый набор включает:39. A kit for determining mRNA levels and / or protein levels in any one or more of the genes disclosed in tables 5-14 of the present description, in a biological sample, said kit comprising: а) полинуклеотид гена, раскрытого в настоящем описании, или его фрагмент;a) a polynucleotide of the gene disclosed in the present description, or a fragment thereof; b) нуклеотидную последовательность, комплементарную таковой из (а);b) a nucleotide sequence complementary to that of (a); с) полипептид, кодируемый геном, раскрытым в настоящем описании, или его фрагмент; илиc) a polypeptide encoded by the gene disclosed herein, or a fragment thereof; or (d) антитело к полипептиду, кодируемому геном, раскрытым в настоящем описании, или его фрагмент, где компоненты (а), (b), (c) или (d) могут представлять собой питательный компонент. (d) an antibody to a polypeptide encoded by the gene disclosed herein, or a fragment thereof, wherein components (a), (b), (c) or (d) can be a nutritional component.
RU2011106036/10A 2008-07-18 2009-07-20 Method of increasing life quality of sexually mature animal RU2513698C2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12/176,331 US8252742B2 (en) 2004-12-30 2008-07-18 Methods for enhancing the quality of life of a senior animal
US12/176,331 2008-07-18
PCT/US2009/051114 WO2010009458A1 (en) 2008-07-18 2009-07-20 Methods for enhancing the quality of life of a senior animal

Publications (2)

Publication Number Publication Date
RU2011106036A true RU2011106036A (en) 2012-08-27
RU2513698C2 RU2513698C2 (en) 2014-04-20

Family

ID=41056782

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2011106036/10A RU2513698C2 (en) 2008-07-18 2009-07-20 Method of increasing life quality of sexually mature animal

Country Status (10)

Country Link
US (3) US8252742B2 (en)
EP (2) EP2315533A1 (en)
JP (2) JP2011528555A (en)
CN (2) CN103766663A (en)
AU (1) AU2009270702B2 (en)
BR (1) BRPI0915979A8 (en)
CA (1) CA2731069C (en)
RU (1) RU2513698C2 (en)
WO (1) WO2010009458A1 (en)
ZA (1) ZA201101282B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005322887B2 (en) * 2004-12-30 2010-03-11 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
US8252742B2 (en) 2004-12-30 2012-08-28 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
ES2534246T3 (en) * 2010-05-12 2015-04-21 Hill's Pet Nutrition, Inc. Methods for diagnosis, control and prophylaxis of inflammation and mitigation of inflammatory conditions in canines
EP2568823B1 (en) * 2010-05-12 2016-04-27 Hill's Pet Nutrition, Inc. Methods of diagnosis, control and prophylaxis of inflammation and mitigation of inflammatory conditions in felines
WO2012087486A1 (en) * 2010-12-20 2012-06-28 Hill's Pet Nutrition, Inc. Pet food compositions for inducing a satiety response
KR102100091B1 (en) 2011-04-13 2020-04-14 아지노모토 가부시키가이샤 Nutritional composition
US20130059028A1 (en) * 2011-09-01 2013-03-07 Julie Marie Foy Compositions and Methods for Providing a Life-Stage-Appropriate Animal Diet
BR112016010014A2 (en) 2013-11-12 2017-12-05 Hills Pet Nutrition Inc improved hydration level in a cat
EP3152307A4 (en) * 2014-06-06 2018-05-02 Berg LLC Methods of treating a metabolic syndrome by modulating heat shock protein (hsp) 90-beta
CN104026404B (en) * 2014-06-10 2016-02-24 贵州省台江县禹洋农业发展有限公司 A kind of senescence phase dog grain
CA2975217C (en) 2015-02-13 2023-08-15 Mars, Incorporated Pet food feeding system
CN104982668B (en) * 2015-07-21 2016-08-17 广州市优百特饲料科技有限公司 A kind of feed fat powder powder and preparation method thereof
GB201522304D0 (en) * 2015-12-17 2016-02-03 Mars Inc Food product for reducing muscle breakdown
WO2017159741A1 (en) * 2016-03-16 2017-09-21 味の素株式会社 Agent for improving physical fitness
CN109310115A (en) * 2016-12-15 2019-02-05 雀巢产品技术援助有限公司 Composition and method for small-sized canid
AU2016433750B2 (en) 2016-12-27 2020-04-09 Hill's Pet Nutrition, Inc. Pet food compositions
CA2996780A1 (en) * 2017-02-28 2018-08-28 Abl Ip Holding Llc Autonomous electronics platform for light fixtures with integral thermal management properties
CN107184598A (en) * 2017-04-28 2017-09-22 深圳市众康动保科技有限公司 A kind of pet heart disease composite tablet
JP7103270B2 (en) 2019-02-25 2022-07-20 トヨタ自動車株式会社 Vehicle occupant protection device
US20240081374A1 (en) * 2022-09-14 2024-03-14 Société des Produits Nestlé S.A. Compositions and methods utilizing southern ocean mackerel oil for providing health benefits in an animal
WO2024069273A1 (en) * 2022-09-30 2024-04-04 Societe Des Produits Nestle Sa Methods for providing health benefits in animals

Family Cites Families (170)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2980716A (en) 1954-06-11 1961-04-18 Research Corp Method for preparing 6, 8-dihalooctanoic esters
US3202414A (en) 1962-01-15 1965-08-24 Gen Motors Corp Vehicle door actuator
US3202514A (en) 1963-07-15 1965-08-24 Gen Foods Corp Animal food and method of making the same
US6090414A (en) 1970-05-20 2000-07-18 Life Science Labs, Inc. Method and composition to reduce cancer incidence
US3946123A (en) 1975-03-10 1976-03-23 Star-Kist Foods, Inc. Canned pet food
US4053647A (en) 1975-12-12 1977-10-11 Samuel Prussin Pet food product and process of producing such
JPS5519090Y2 (en) 1976-06-14 1980-05-06
AU524005B2 (en) 1978-07-05 1982-08-26 Jerky Treats Inc. Meat containing animal biscuit or kibble
US4247562A (en) 1978-12-21 1981-01-27 The Quaker Oats Company Moist pet food with blood chunks and a fluid gravy system
JPS57132849A (en) 1981-02-12 1982-08-17 Sanwa Kagaku Kenkyusho:Kk Preparation of aseptic health feed
JPS57132849U (en) 1981-02-14 1982-08-19
US5004624A (en) 1983-03-14 1991-04-02 Star-Kist Foods, Inc. Semi-moist pet food having free gravy and process for preparation thereof
EP0270690B1 (en) 1986-06-21 1991-05-15 Dainippon Ink And Chemicals, Inc. Drug for treatment and prophylaxis of kidney and liver diseases
US5030458A (en) 1989-11-27 1991-07-09 Shug Austin L Method for preventing diet-induced carnitine deficiency in domesticated dogs and cats
US4997672A (en) 1987-03-10 1991-03-05 Virginia Commonwealth University Salt taste enhancer
ES2043897T3 (en) 1988-01-28 1994-01-01 Koeltringer Peter COMBINATION PREPARATION, ESPECIALLY FOR THE TREATMENT OF NERVOUS CELL DISEASES.
US6977167B2 (en) 1988-09-07 2005-12-20 Martek Biosciences Corporation Mixtures of omega-3 and omega-6 highly unsaturated fatty acids from euryhaline microorganisms
US4997671A (en) 1988-09-09 1991-03-05 Nabisco Brands, Inc. Chewy dog snacks
US5114704A (en) 1989-05-30 1992-05-19 Nabisco Brands, Inc. Raw hide having a coating containing an inorganic pyrophosphate
IE904034A1 (en) 1989-11-09 1991-05-22 Asta Medica Ag A medicament containing r-ó-lipoic acid or s-ó-lipoic acid¹as active substance
US6746678B1 (en) 1991-02-22 2004-06-08 Howard K. Shapiro Method of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with medicaments
US5419283A (en) 1992-04-08 1995-05-30 Ciuffo Gatto S.R.L. Animal chew toy of starch material and degradable ethylene copolymer
US5569670A (en) 1992-06-05 1996-10-29 Asta Medica Aktiengesellschaft Combination medications containing alpha-lipoic acid and related
US5624896A (en) 1992-06-09 1997-04-29 Neorx Corporation Clearing agents useful in pretargeting methods
US5292538A (en) 1992-07-22 1994-03-08 Metagenics, Inc. Improved sustained energy and anabolic composition and method of making
DE4235912C2 (en) 1992-10-23 2002-12-05 Viatris Gmbh Process for the preparation of crystalline thioctic acid and its use
JP3347381B2 (en) 1993-01-27 2002-11-20 協和醗酵工業株式会社 Pet food
US5532010A (en) 1993-05-28 1996-07-02 Nabisco, Inc. Coated canine biscuits and preparation process
US5339771A (en) 1993-09-15 1994-08-23 Axelrod Herbert R Animal chew toy containing animal meal
CA2176709A1 (en) 1993-11-15 1995-05-26 Howard R. Higley Method of treating renal disease by administering igf-i and igfbp-3
CA2147109A1 (en) 1994-04-18 1995-10-19 Gregory A. Reinhart Pet food product containing omega-6 and omega-3 fatty acids and process for reducing inflammatory skin responses
US7105607B2 (en) * 1994-04-19 2006-09-12 Applied Elastomerics, Inc. Tear resistant gels, composites, and articles
US6458767B1 (en) 1994-05-04 2002-10-01 The Uab Research Foundation Use of peptides inhibitory for thrombospondin dependent TGF-β activation in the treatment of kidney disease
DE4427079C2 (en) 1994-07-30 2002-12-19 Viatris Gmbh Process for the racemization of enantiomers of alpha-lipoic acid
US5976548A (en) 1994-11-08 1999-11-02 Viva America Marketing, Inc. Nutritional supplement composition and use
US5599835A (en) 1994-11-23 1997-02-04 Fischer; Frederick B. Use of DL-lipoic acid as a medical food in the treatment of diabetes mellitus
US5730988A (en) 1995-04-20 1998-03-24 Lynntech, Inc. Nutritional supplements for improving glucose metabolism
US6184227B1 (en) 1995-07-21 2001-02-06 Savvipharm Inc. Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases
FR2738741B1 (en) 1995-09-19 1997-12-05 Oreal COMPOSITION FOR DYEING KERATINIC FIBERS, CONTAINING AN ANTAGONIST OF SUBSTANCE P
JP3798464B2 (en) * 1996-04-09 2006-07-19 株式会社海洋バイオテクノロジー研究所 Novel microalgae and method for producing highly unsaturated fatty acids using the same
CA2208392C (en) 1996-06-21 2002-09-03 University Of Guelph Method for enriching docosahexaenoic acid in expressed milk of dairy cattle
US5977162A (en) 1996-09-16 1999-11-02 Seidman; Michael D. Therapeutic treatment for auditory function
CA2269806C (en) 1996-10-28 2006-01-24 Bernhard H. Van Lengerich Embedding and encapsulation of controlled release particles
US5976568A (en) 1997-02-21 1999-11-02 Medical Doctors' Research Institute, Inc. Modular system of dietary supplement compositions for optimizing health benefits and methods
US6232346B1 (en) 1997-03-27 2001-05-15 Michael J. Sole Composition for improvement of cellular nutrition and mitochondrial energetics
US6080788A (en) 1997-03-27 2000-06-27 Sole; Michael J. Composition for improvement of cellular nutrition and mitochondrial energetics
US6133323A (en) 1997-04-09 2000-10-17 The Iams Company Process for enhancing immune response in animals using β-carotene as a dietary supplement
US5851573A (en) 1997-04-29 1998-12-22 The Iams Company Pet food composition for large breed puppies and method for promoting proper skeletal growth
US6264994B1 (en) 1997-05-15 2001-07-24 University Of Washington Compositions for treating alzheimer's disease and other amyloidoses
US5883083A (en) 1997-06-09 1999-03-16 Harlmen, Inc. Dietary supplement for alleviating behavioral problems in canines and reducing seizures in canines and felines
US5916912A (en) 1997-06-16 1999-06-29 The Regents Of The University Of California Dietary composition for enhancing metabolism and alleviating oxidative stress
DE19726519A1 (en) 1997-06-23 1998-12-24 Asta Medica Ag Process for the production of dry thioctic acid
EP0891719A1 (en) 1997-07-14 1999-01-20 N.V. Nutricia Nutritional composition containing methionine
US6039952A (en) 1997-10-22 2000-03-21 The Iams Company Composition and method for improving clinical signs in animals with renal disease
GB9722361D0 (en) 1997-10-24 1997-12-17 Pharma Nord Uk Ltd Pharmaceutical formulation for treating liver disorders
US6365623B1 (en) 1997-11-17 2002-04-02 Nicholas V. Perricone Treatment of acne using lipoic acid
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
DE19810336A1 (en) 1998-03-11 1999-09-23 Asta Medica Ag Thioctic acid useful for pharmaceutical, cosmetic and nutritional purposes e.g. as an analgesic, antiinflammatory or antioxidant
US6117477A (en) 1998-03-18 2000-09-12 Kal Kan Foods, Inc. Multicomponent food product and methods of making and using the same
US6306430B1 (en) * 1998-04-16 2001-10-23 The Iams Company Process for decreasing adiposity using vitamin a as a dietary supplement
RU2131677C1 (en) 1998-05-05 1999-06-20 Научно-производственная фирма "Аквазинэль" Fodder additive "biovitos"
US6492325B1 (en) 1998-05-22 2002-12-10 Boys Town National Research Hospital Use of α1β1 integrin receptor inhibitors and TGF-β1 inhibitors in the treatment of kidney disease
US6197340B1 (en) 1998-05-28 2001-03-06 Medical Research Institute Controlled release lipoic acid
JP2000014392A (en) * 1998-07-07 2000-01-18 Ikeda Shokken Kk Production of glyceride containing highly unsaturated fatty acid
DE19834608A1 (en) 1998-07-31 2000-02-03 Basf Ag Crystal modification of lipoic acid
US6136339A (en) 1998-08-21 2000-10-24 Gardiner; Paul T. Food supplements and methods comprising lipoic acid and creatine
IT1302307B1 (en) 1998-09-01 2000-09-05 Sigma Tau Healthscience Spa COMPOSITION WITH ANTIOXIDANT ACTIVITY AND FOR IMPROVING THE METABOLIC USE OF GLUCOSE, INCLUDING ACETYL
US6203825B1 (en) * 1998-09-02 2001-03-20 Heska Corporation Method and composition to protect an obligate carnivore from a disease of abnormal carbohydrate metabolism
FR2786100B1 (en) 1998-11-24 2002-03-01 Aventis Laboratoire NEW THERAPEUTIC APPLICATION OF NICERGOLIN
US20040029175A1 (en) 1998-12-21 2004-02-12 Comper Wayne D. Method for kidney disease detection
MXPA01006404A (en) 1998-12-21 2003-06-06 Univ Monash Kidney disease detection and treatment.
AUPP784398A0 (en) 1998-12-21 1999-01-21 Monash University Kidney disease detection and treatment
US6284786B1 (en) 1999-02-16 2001-09-04 The Center For The Improvement Of Human Functioning, Int'l., Inc. Treatment of cancer using lipoic acid in combination with ascorbic acid
US6238708B1 (en) * 1999-02-23 2001-05-29 The Iams Company Composition and process for controlling glucose metabolism in companion animals by dietary starch
AUPP887399A0 (en) 1999-02-24 1999-03-25 Bartlett Grain Pty Ltd Animal feed formulae for the nutritional enrichment of foodstuffs
ATE289586T1 (en) 1999-03-01 2005-03-15 Pfizer Prod Inc OXAMIC ACIDS WITH A CYANO GROUP AS LIGANDS FOR THE THYROID RECEPTOR
IT1306130B1 (en) 1999-04-16 2001-05-30 Sigma Tau Healthscience Spa COMPOSITION INCLUDING A CARNITINE AND GLUTATIONE, SUITABLE TO INCREASE THE ABSORPTION OF GLUTATIONE BY SYNERGIZING THE EFFECTS.
BR0010999A (en) 1999-05-27 2002-02-19 Iams Company Process and product for improving the immune response in a companion animal, processes for optimizing immune cells in a dog and for optimizing vaccine recognition in a dog, and, pet food product for improving the immune response in a pet. company
US6365211B1 (en) 1999-06-18 2002-04-02 The Procter & Gamble Co. Cooking aid with reduced foaming
JP4098927B2 (en) * 1999-08-03 2008-06-11 花王株式会社 Oil composition
WO2001021208A1 (en) 1999-09-23 2001-03-29 Juvenon Corporation Nutritional supplement for increased energy and stamina
US6426362B1 (en) 1999-10-08 2002-07-30 Galileo Laboratories, Inc. Formulations of tocopherols and methods of making and using them
NZ518739A (en) 1999-11-02 2004-12-24 Depomed Inc Pharmacological inducement of the fed mode for enhanced drug administration to the stomach
WO2001032168A1 (en) 1999-11-03 2001-05-10 Juvenon, Inc. Method of treating benign forgetfulness
NL1013817C2 (en) * 1999-12-10 2001-06-12 Stork Mps Bv Coagulation solution for coagulating a collagen.
US6379727B1 (en) 1999-12-29 2002-04-30 John F. Addy Flavoring system for pet foods
US20030060503A1 (en) 2000-01-25 2003-03-27 Juvenon, Inc. Nutritional supplements for mature pets
WO2001058271A1 (en) 2000-01-25 2001-08-16 Juvenon, Inc. Nutritional supplements for aged pets
EP1255454A2 (en) 2000-02-01 2002-11-13 Muscletech Research and Development Inc. Alpha lipoic acid based food supplement to increase lean muscle mass and strength
EG22407A (en) * 2000-02-17 2003-01-29 Iams Company Method for improving bone modeling and chondrocyte functioning in growing canines
CO5280054A1 (en) 2000-03-22 2003-05-30 Nestle Sa FOOD FOR DENTALLY BENEFICIAL PETS AND ITS MANUFACTURING METHOD
JP4487376B2 (en) 2000-03-31 2010-06-23 味の素株式会社 Kidney disease treatment
EP1155627A1 (en) 2000-05-18 2001-11-21 Belovo Eggs & Egg Products Eggs with balanced lipid composition
US6436463B1 (en) * 2000-06-26 2002-08-20 Hill's Pet Nutrition, Inc. Pet food composition and method
AU2000266391A1 (en) 2000-08-10 2002-02-25 Renessen Llc Products comprising corn oil and corn meal obtained from high oil corn
US6592863B2 (en) 2000-08-22 2003-07-15 Nestec S.A. Nutritional composition
EP1324671A4 (en) 2000-09-07 2005-09-07 Univ Maryland Biotech Inst Use of arachidonic acid for enhanced culturing of fish larvae and broodstock
US6784159B2 (en) 2000-09-29 2004-08-31 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture Triterpene saponins from soybeans for treating kidney disease
US6277842B1 (en) 2000-10-17 2001-08-21 James Alexander Carthron Dietary supplemental method for fat and weight reduction
US20020052402A1 (en) 2000-10-31 2002-05-02 Colgate-Palmolive Company Composition and method
US20090156658A1 (en) 2000-10-31 2009-06-18 Hill's Pet Nutrition, Inc. Antioxidant-Containing Food Composition For Use In Inhibiting Histamine Pathways In Companion Animals
US20020076469A1 (en) 2000-10-31 2002-06-20 Colgate-Palmolive Company Composition and method
US8669282B2 (en) 2000-10-31 2014-03-11 Hill's Pet Nutrition, Inc. Companion animal compositions including lipoic acid and methods of use thereof
US20020115710A1 (en) 2000-10-31 2002-08-22 Zicker Steven Curtis Composition and method
US20020076470A1 (en) 2000-10-31 2002-06-20 Colgate-Palmolive Company Composition and method
US8592479B2 (en) 2000-10-31 2013-11-26 Hill's Pet Nutrition, Inc. Antioxidant-containing food composition for use in enhancing antiviral immunity in companion animals
WO2002052951A1 (en) 2000-12-29 2002-07-11 Martin Francis Gannon An animal food product
BR0207948A (en) 2001-03-09 2004-07-27 Produits Nestel S A Soc D Composition that improves age-related physiological deficits and increases longevity
US7001610B2 (en) 2001-04-23 2006-02-21 Omeganutrel Inc. Food supplement and use thereof for elevating levels of essential fatty acids in livestock and products therefrom
WO2002091853A1 (en) 2001-05-14 2002-11-21 Martek Biosciences Corporation A method of improving the flavor, tenderness and overall consumer acceptability of poultry meat
US6596762B2 (en) 2001-05-17 2003-07-22 The Regents Of The University Of Colorado Antioxidant compositions and use for treatment of hepatic steatosis and steatohepatitis
US6596768B2 (en) 2001-05-22 2003-07-22 Church & Dwight Co., Inc. Unsaturated lipid-enriched feedstock for ruminants
US6902739B2 (en) 2001-07-23 2005-06-07 Nutracea Methods for treating joint inflammation, pain, and loss of mobility
GB0119052D0 (en) 2001-08-03 2001-09-26 Mars Uk Ltd Foodstuff
US6923960B2 (en) 2001-10-03 2005-08-02 Vsl Pharmaceuticals Inc. Antioxidant combination composition and use thereof
GB0129864D0 (en) 2001-12-13 2002-02-06 Danisco Animal feed
US20030190343A1 (en) 2002-03-05 2003-10-09 Pfizer Inc. Palatable pharmaceutical compositions for companion animals
EP1350435B1 (en) 2002-04-05 2010-12-22 Societe Des Produits Nestle S.A. Compositions and methods for promoting lipid assimilation in pets
US20030194478A1 (en) 2002-04-12 2003-10-16 Davenport Gary Mitchell Dietary methods for canine performance enhancement
US6733793B2 (en) 2002-06-04 2004-05-11 Metaproteomics, Llc Oral composition with insulin-like activities and methods of use
US6572899B1 (en) 2002-07-03 2003-06-03 Vitacost.Com, Inc. Memory loss treatment formulation
AU2003252324A1 (en) 2002-08-07 2004-03-11 Kao Corporation Fat composition
JP2004141130A (en) 2002-08-28 2004-05-20 Mars Inc Dog food for exclusive use for specific dog species
US6974841B1 (en) 2002-09-27 2005-12-13 Rapisarda Family Irrevocable Trust Pet anti-aging wellness supplement
US8841344B2 (en) 2002-10-03 2014-09-23 Hill's Pet Nutrition, Inc. Method of using omega-3 fatty acids
JP3813585B2 (en) * 2003-01-23 2006-08-23 花王株式会社 Method for producing diglyceride
RU2221456C1 (en) 2003-03-11 2004-01-20 Общество с ограниченной ответственностью "Арсентех" Biologically active substance, biologically active supplement to food, pharmaceutical preparation, biologically active supplement for feeding animal, veterinary preparation, fertilizer, activator of microbiological process, oral nutrition, perfume-cosmetic agent, hygienic agent, dairy foodstuff, confectionery, baked goods, butter-fat foodstuff, sauce, alcohol drink, nonalcoholic beverage, piscine foodstuff, meat foodstuff, macaroni article, chewing gum, beer
EP1633768A2 (en) 2003-05-13 2006-03-15 The Regents Of The University Of Colorado Diagnostic and therapeutic treatments related to mitochondrial disorders
US7202270B2 (en) 2003-06-20 2007-04-10 Sami Labs Limited Convenient stable non-hygroscopic crystalline solid forms of racemic and chiral LA-plus salts: process for their manufacture and uses
CN1816284A (en) * 2003-07-03 2006-08-09 希尔氏宠物营养品公司 Compositions and methods for decreasing age-related deterioration in metal activities in companion animals
US8633247B2 (en) * 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Method for decreasing cartilage damage in dogs
WO2005023021A1 (en) * 2003-09-02 2005-03-17 Bbk Bio Corporation Diet food
US7078064B2 (en) 2003-12-03 2006-07-18 George Zabrecky Compositions and methods useful for treating and preventing chronic liver disease, chronic HCV infection and non-alcoholic steatohepatitis
ITMI20040069A1 (en) * 2004-01-21 2004-04-21 Tiberio Bruzzese USE OF HIGH CONCENTRATION N-3 FATTY ACID COMPOSITIONS FOR THE TREATMENT OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM
US8034373B2 (en) 2004-04-16 2011-10-11 Nestec S. A. Methods and compositions for reducing oxidative stress in an animal
US20050266051A1 (en) 2004-05-27 2005-12-01 The Procter & Gamble Company Pet food compositions and methods
US20060002985A1 (en) 2004-07-02 2006-01-05 Zicker Steven C Compositions and methods for decreasing age-related deterioration in mental activities in companion animals
EP1794316B1 (en) * 2004-08-30 2018-10-03 Hill's Pet Nutrition, Inc. Genome-based diet design
RU2433819C2 (en) * 2004-11-09 2011-11-20 Хилл'С Пет Ньютришн, Инк. Application of antioxidants for gene modulation
US20090176864A1 (en) 2004-11-24 2009-07-09 Hill's Pet Nutrition, Inc. Methods For Improving Hepatic and Immune Function In An Animal
CN101107012A (en) 2004-11-24 2008-01-16 希尔氏宠物营养品公司 Methods for improving liver clearance of xenobiotic substances in an animal
RU2394561C2 (en) 2004-11-24 2010-07-20 Хилл`С Пет Ньютришн, Инк. Methods of increasing immune response in animal
US8168161B2 (en) 2004-12-22 2012-05-01 Hill's Pet Nutrition, Inc. Method to promote oral health in companion animals
US8647660B2 (en) 2004-12-29 2014-02-11 Hill's Pet Nutrition, Inc. Combination of limited nutrients and enhanced dietary antioxidants to impart improved kidney health
JP2008525528A (en) 2004-12-29 2008-07-17 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド Method for suppressing learning and / or memory decline in animals
AU2005322887B2 (en) 2004-12-30 2010-03-11 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
PL1833291T3 (en) * 2004-12-30 2017-05-31 Commonwealth Scientific And Industrial Research Organisation Method and means for improving bowel health
US8252742B2 (en) 2004-12-30 2012-08-28 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
EP1835817B1 (en) * 2004-12-30 2018-02-14 Hill's Pet Nutrition, Inc. Compositions for feline consumption
EP1852499A4 (en) * 2005-02-22 2009-05-06 Mochida Pharm Co Ltd Neurotization promoting agent
EP1888727B1 (en) * 2005-05-04 2015-04-15 Pronova BioPharma Norge AS New dha derivatives and their use as medicaments
CA2613792C (en) * 2005-06-29 2014-01-14 Hill's Pet Nutrition, Inc. Methods and compositions for the prevention and treatment of inflammatory disease
DK1906912T3 (en) 2005-07-14 2012-12-03 Hills Pet Nutrition Inc Method of Extending the Life of an Animal
JP4903796B2 (en) 2005-08-17 2012-03-28 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド Methods and compositions for prevention and treatment of kidney disease
NZ567293A (en) * 2005-09-20 2011-12-22 Simplot Co J R Low acrylamide foods obtained from plants with reduced asparagine levels
BRPI0618485A2 (en) * 2005-11-10 2012-05-08 Hills Pet Nutrition Inc method, composition and kit for improving skin health and / or coat quality of an animal, means for communicating information or instructions, and use of a composition
WO2007062325A1 (en) * 2005-11-18 2007-05-31 Hill's Pet Nutrition, Inc. Methods for reducing the amount of proinflammatory substance in animal tissue or body fluid
DE602006008985D1 (en) * 2005-12-16 2009-10-15 Nutricia Nv COMPOSITION CONTAINING OLIGOSACCHARIDES AS SOLUBLE BALLASTS FOR USE AGAINST MUSCLE WOOD
JP2009520824A (en) * 2005-12-20 2009-05-28 セネストラ エルエルシー Omega 3 fatty acid preparation
NZ569676A (en) * 2005-12-21 2012-03-30 Brudy Technology S L Use of DHA, EPA or DHA-derived EPA for treating a pathology associated with cellular oxidative damage
RU2449554C2 (en) * 2006-02-01 2012-05-10 Нестек С.А. Food systems and longevity enhancement methods
FR2903860B1 (en) * 2006-07-21 2010-12-31 Royal Canin Sa DRY FOOD TO REDUCE THE APPETITE OF DOGS
MX2009001422A (en) * 2006-08-09 2009-02-19 Iams Company Methods of improving bone health and muscle health.
US7282225B1 (en) 2006-09-27 2007-10-16 Occular Technologies, Inc. Composition and methods for improving retinal health
WO2008051795A2 (en) * 2006-10-20 2008-05-02 Dow Global Technologies Inc. Preventing or reducing oxidative stress or oxidative cell injury by the administration of a water-insoluble cellulose derivative
US20080299286A1 (en) 2007-06-04 2008-12-04 David B Josephson Palatability enhancing compositions and foods for pets, and methods regarding the same
CA2691691C (en) 2007-06-20 2013-09-24 Seth J. Baum Compositions and methods of treating chronic kidney disease
US20080317884A1 (en) 2007-06-22 2008-12-25 Jewell Dennis E Enhancing Disease Resistance In An Animal
WO2009088433A1 (en) 2008-01-04 2009-07-16 Nestec S.A. Compositions comprising unsaturated fatty acids and nitric oxide releasing compounds and use thereof for enhancing congnitive and related functions
EP2320752A1 (en) * 2008-07-18 2011-05-18 Hill's Pet Nutrition, Inc. Method for enhancing the quality of life of a senior animal

Also Published As

Publication number Publication date
BRPI0915979A8 (en) 2017-10-10
US20120289430A1 (en) 2012-11-15
CA2731069A1 (en) 2010-01-21
CN102186359B (en) 2016-03-23
BRPI0915979A2 (en) 2015-08-11
CN103766663A (en) 2014-05-07
AU2009270702A1 (en) 2010-01-21
WO2010009458A1 (en) 2010-01-21
US8669211B2 (en) 2014-03-11
JP2011528555A (en) 2011-11-24
CA2731069C (en) 2015-10-27
RU2513698C2 (en) 2014-04-20
US20090111877A1 (en) 2009-04-30
ZA201101282B (en) 2014-07-30
CN102186359A (en) 2011-09-14
JP2015077139A (en) 2015-04-23
US8252742B2 (en) 2012-08-28
US20140018528A1 (en) 2014-01-16
US8759283B2 (en) 2014-06-24
EP2315533A1 (en) 2011-05-04
EP3155904A3 (en) 2017-06-28
EP3155904A2 (en) 2017-04-19
JP6178302B2 (en) 2017-08-09
AU2009270702B2 (en) 2012-11-15

Similar Documents

Publication Publication Date Title
RU2011106036A (en) WAYS TO IMPROVE THE QUALITY OF LIFE OF THE MATURE ANIMAL ANIMAL
Pal et al. A review on role of fish in human nutrition with special emphasis to essential fatty acid
Madeira et al. Microalgae as feed ingredients for livestock production and meat quality: A review
JP2011528555A5 (en)
RU2367195C2 (en) Methods of life quality of old animals improvement
RU2362323C2 (en) Method of improving quality of life of growing animal and use of composition thereof
Roo et al. Effect of DHA content in rotifers on the occurrence of skeletal deformities in red porgy Pagrus pagrus (Linnaeus, 1758)
Alfaia et al. Current feeding strategies to improve pork intramuscular fat content and its nutritional quality
RU2011105794A (en) METHODS FOR IMPROVING THE QUALITY OF LIFE OF ELDERLY ANIMALS
JP2011528556A5 (en)
RU2009135260A (en) COMPOSITIONS AND METHODS FOR CHANGE GENE EXPRESSION
Cividini et al. Fatty acid composition of lamb meat from the autochthonous Jezersko–Solčava breed reared in different production systems
BRPI0710665A2 (en) feed formulations containing docosahexaenoic acid
Okruszek Fatty acid composition of muscle and adipose tissue of indigenous Polish geese breeds
RU2012132294A (en) COMPOSITIONS CONTAINING GINGER FOR EASY TO PREVENT OR PREVENT INFLAMMATORY CONDITIONS
Cools et al. Dose‐response effect of fish oil substitution in parturition feed on erythrocyte membrane characteristics and sow performance
KR20100080781A (en) Treatment of pigs for reducing the feed conversion ratio or increasing the growth rate
Szczerbińska et al. Effect of the diet with common flax (Linum usitatissimum) and black cumin seeds (Nigella sativa) on quail performance and reproduction.
BRPI0924842B1 (en) Feeding of poultry including fatty acids
JP2017534299A (en) Feeding algae at low doses to cattle to produce high levels of omega-3 in beef
Al-Rubeii et al. Effect of different levels of flax seed powder as a source of omega-3 on the carcass characteristics of Karadi lambs
Yadav et al. An overview on the use of oil in fish diet
TKACHUK et al. MORPHOLOGICAL AND BIOCHEMICAL PARAMETERS OF PIG BLOOD WHEN USED FEEDING FEED ADDITIVES LG-MAX AND SEL-PLEX.
Andri et al. Effect of fish oil alone or in combination with tomato powder supplementation in feed on egg quality of local ducks
Swarna et al. Effect of unsaturated to saturated fatty acids ratio of supplemental fat in the diet with or without l-carnitine on performance of broiler chicken

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20180721